Skip to content

Public Health Impact of Unilateral Spatial Neglect

Public Health Impact of Unilateral Spatial Neglect

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05792969
Acronym
IMPAssNEGLECT
Enrollment
168
Registered
2023-03-31
Start date
2022-02-07
Completion date
2024-11-30
Last updated
2023-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spatial Neglect

Brief summary

This multi-center project aims to quantify the socio-medical costs associated with Unilateral Spatial Neglect (USN) resulting from acquired brain injury (stroke) and to measure the effects of USN rehabilitation on functional autonomy, quality of life and psychological well-being of patients affected by this syndrome, considering the repercussions on a psychological level and on the quality of life of caregivers. To this end, the experimenters will administer to right brain-injured patients - with (Experimental Group) or without (Control Group) USN - who undertook a rehabilitation process, a series of questionnaires: Activities of daily living (ADL), Barthel Index; Instrumental activities of daily living scale (I-ADL:), the Health Related Quality of Life questionnaire (EQ-5D-5L), the Geriatric Depression Scale (GDS), and the State-Trait Anxiety Inventory (STAI-Y). The aforementioned tests will be administered before the start of the rehabilitation (baseline) and after one month, 3, 6 and 12 months after the end of the rehabilitation. The impact of USN and its treatment on the psycho-physical well-being of the caregiver will be measured through the Caregiver Burden Inventory questionnaire, which will be administered with the same timing (baseline, 1-3-6-12 months after rehabilitation). The costs of USN will be surveyed through an ad-hoc questionnaire, which includes a version intended for patients and one for caregivers, in order to identify the resources consumed due to the disease and the expenses taken during the observation period, to be estimated subsequently in monetary terms (€).

Interventions

BEHAVIORALFunctional measures and public health outcomes

Questionnaires: * Activities of daily living - ADL * Barthel Index * Instrumental activities of daily living- IADL * Health Related Quality of Life - EQ-5D-5L * Geriatric Depression Scale (GDS) * State-Trait Anxiety Inventory - STAI-Y) * Caregiver Burden Inventory questionnaire (CBI)

Sponsors

Istituto Auxologico Italiano
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* age \> 18 years; * right brain injury due to stroke (of ischemic or hemorrhagic origin); * Disease duration ≥ 10 days; * Participation to a rehabilitation program; For stroke patients with USN: \- clinical diagnosis of USN, placed by the specialist of reference, on the basis of clinical indicators and the results obtained by the patient in the routine neuropsychological evaluation (by means of a battery of standardized psychometric tests calibrated in the Italian population).

Exclusion criteria

* Other brain disorders

Design outcomes

Primary

MeasureTime frameDescription
Change in the Activities of Daily Living scale (ADL)At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatmentTo evaluate the degree of patients' functional independence in everyday life
Change in the Instrumental Activities of Daily Living scale (I-ADL)At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatmentTo evaluate the degree of patients' functional independence instrumental activities, including, e.g., cleaning, cooking, and managing finances.
Change in the Health-Related Quality of Life (EQ-5D-5L)At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatmentA brief scale assessing patient's health-related quality of life
Change in the Geriatric Depression Scale (GDS)At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatmentA scale assessing patients' depressive symptoms
Change in the State-Trait Anxiety Inventory (STAI-Y)At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatmentA scale assessing patients' anxiety symptoms
Change in the Caregiver Burden Inventory questionnaire (CBI)At baseline (at the beginning of the treatment) and after 1, 3, 6, and 12 months after the end of the treatmentA scale that assess caregivers' physical and psychological burden
Financial impact of USN1 month after the end of the treatmentA questionnaire about health-related costs associated to the disease (e.g., heath examinations, medicines, sick leaves)

Countries

Italy

Contacts

Primary ContactNadia Bolognini, PhD
n.bolognini@auxologico.it+39025821

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026